Fan Lin-Wei et al. found that SNX20 expression was positively correlated with PD-L1 expression in lung cancer, and increasing the levels of SNX20 and PD-L1 resulted in a clinical response to PD-1 inhibitors in lung cancer [55]. The gene discussed is SNX20; the disease is lung cancer.